Nikki De Rouw
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Prophylactic folinic acid prevents pemetrexed myelosuppression: A randomized trial toward safer treatment with chemotherapy in non-small cell lung cancer.
Journal: Neoplasia (New York, N.Y.)
Published: November 21, 2025
Early-onset hematological toxicity of docetaxel and survival in non-small cell lung cancer patients in the immune checkpoint inhibition era.
Journal: Cancer treatment and research communications
Published: September 01, 2025
Omission of dexamethasone in paclitaxel premedication regimens: protocol of the multicentre, randomised, non-inferiority DEXASTOP trial.
Journal: BMJ open
Published: April 25, 2025
Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.
Journal: Clinical pharmacology and therapeutics
Published: February 03, 2025
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study.
Journal: Clinical lung cancer
Published: December 16, 2024
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed.
Journal: Cancer chemotherapy and pharmacology
Published: July 20, 2024
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.
Journal: Targeted oncology
Published: May 20, 2024
Folinic Acid to Prevent Pemetrexed-Associated Neutropenia After Intrathecal Administration: A Quick Win.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 04, 2023
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.
Journal: Targeted oncology
Published: March 15, 2023
Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.
Journal: Cancer chemotherapy and pharmacology
Published: July 10, 2022
Effect of conventional hemodialysis on the apixaban plasma concentration.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis
Published: June 08, 2022
The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer.
Journal: Clinical pharmacology and therapeutics
Published: November 15, 2021
Last Updated: 09/26/2026